Kamada Ltd. Reports Strong Growth and Raises Guidance
Company Announcements

Kamada Ltd. Reports Strong Growth and Raises Guidance

Kamada Ltd (IL:KMDA) has released an update.

Kamada Ltd. has reported a robust start to 2024, showcasing a 23% increase in first-quarter revenues, which amounted to $37.7 million, and a significant 96% surge in adjusted EBITDA to $7.5 million. The company’s positive performance, driven by strong U.S. sales of KEDRAB® and CYTOGAM®, has led to an upward revision of its full-year revenue and EBITDA forecasts. Kamada remains focused on growth, leveraging financial strength to explore new business opportunities and expecting double-digit growth rates to continue beyond 2024.

For further insights into IL:KMDA stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyKamada initiated with a Buy at Stifel
TheFlyKamada raises FY24 revenue to $158M-$162M from $156M-$160M
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!